AIM-Harvard/TrialPanorama-filtered huggingface dataset:
Trial: 3397523
Drug: Amitriptyline 50
RxNorm normalized name: amitriptyline 50 mg oral tablet
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Amitriptyline 50 mg
Trial: 1428304
Drug: Cyclobenzaprine (C)
DrugBank: Cyclobenzaprine (DB00924)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Cyclobenzaprine (C) 10 mg
Trial: 1428304
Drug: Cyclobenzaprine (C)
DrugBank: Cyclobenzaprine (DB00924)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Cyclobenzaprine (C) 10 mg plus Ibuprofen (I) 600 mg
Trial: 2413307
Drug: Naloxone (0.4
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Naloxone (0.4 mg i.v.)
Trial: 3935458
Drug: Sulpiride (25
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Sulpiride (25 mg i.v.)
Trial: 3935458
Drug: Naloxone (0.8
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Naloxone (0.8 mg i.v.)
Trial: 31757206
Drug: Doxapram 50
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Doxapram 50 mg
Trial: 29134633
Drug: AZD1419 (inhaled
FDA approved: no
EMA approved: no
PMDA approved: no
Description: AZD1419 (inhaled TLR9 agonist)
Trial: 27035595
Drug: Coffee with
RxNorm normalized name: Coffee bean
DrugBank: Coffee bean (DB10525)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Coffee with 20% milk (175 ml)
Trial: 27035595
Drug: Coffee with
RxNorm normalized name: Coffee bean
DrugBank: Coffee bean (DB10525)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Coffee with 50% milk (175 ml)
Trial: 21147688
Drug: Odanacatib 5
RxNorm normalized name: Odanacatib
DrugBank: Odanacatib (DB06670)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Odanacatib 5 mg daily for 4 weeks
Trial: 21147688
Drug: Zoledronic acid
RxNorm normalized name: Zoledronic Acid
DrugBank: Zoledronic acid (DB00399)
FDA approved: yes
EMA approved: yes
PMDA approved: no
Description: Zoledronic acid (ZA) 4 mg I.V. once at study initiation
Trial: 17650211
Drug: Synbiotic milk
RxNorm normalized name: MILK
DrugBank: Cow milk (DB10543)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Synbiotic milk (Lactobacillus acidophilus strain 74‐2, 10(7) CFU ml(‐1), Bifidobacterium lactis strain 420, 10(7) CFU ml(‐1), 2% inulin) consumed for 4 weeks at 500 ml day(‐1)
Trial: 17650211
Drug: Placebo (2%
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Placebo (2% skimmed milk) consumed for 4 weeks at 500 ml day(‐1)
Trial: 16510462
Drug: Both treatments
RxNorm normalized name: Hongo Killer Treatment
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Both treatments (medical and surgical)
Trial: 14634938
Drug: Triple-injection axillary
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Triple-injection axillary brachial plexus block (group A)
Trial: 10783203
Drug: Streptokinase thrombolytic
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Streptokinase thrombolytic therapy
Trial: 4044777
Drug: 20 micrograms/day
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 20 micrograms/day estradiol infusion
Trial: 4044777
Drug: 90 micrograms/day
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 90 micrograms/day estradiol infusion
Trial: 31848172
Drug: Intralesional steroid
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Intralesional steroid injection followed by balloon dilatation
Trial: 29063390
Drug: 2-year treatment
RxNorm normalized name: miconazole
DrugBank: Miconazole (DB01110)
FDA approved: yes
EMA approved: no
PMDA approved: yes
Description: 2-year treatment group (2YG, N = 112)
Trial: 29063390
Drug: 3-or-more-year treatment
RxNorm normalized name: Sore No More 3 % / 3 % Topical Gel
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 3-or-more-year treatment group (3YG, N = 110)
Trial: 24284387
Drug: 8-12-week treadmill
RxNorm normalized name: deutetrabenazine
DrugBank: Deutetrabenazine (DB12161)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: 8-12-week treadmill exercise program (target lactate 2.0±0.5 mmol l(‐1))
Trial: 16118817
Drug: Insecticide spray
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Insecticide spray
Trial: 8847032
Drug: 20mg Omeprazole
RxNorm normalized name: omeprazole 20 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 20mg Omeprazole tid + 500mg Amoxicillin qid
Trial: 8847032
Drug: 20mg Omeprazole
RxNorm normalized name: omeprazole 20 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 20mg Omeprazole qid + 500mg Amoxicillin qid
Trial: 28681650
Drug: E6011 200
FDA approved: no
EMA approved: no
PMDA approved: no
Description: E6011 200 mg
Trial: 29746133
Drug: Generic formulation
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Generic formulation X1
Trial: 29746133
Drug: Test formulation
RxNorm normalized name: mumps skin test antigen
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Test formulation Y1
Trial: 24062178
Drug: 4CMenB vaccine
RxNorm normalized name: Pertussis vaccine
DrugBank: Pertussis vaccine (DB15274)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 4CMenB vaccine (5th dose)
Trial: 24062178
Drug: Control group
RxNorm normalized name: meningococcal group B vaccine Prefilled Syringe [Trumenba]
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Control group (MenB vaccine-naive participants receiving 4CMenB)
Trial: 14600189
Drug: Long-acting beta2-agonists
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Long-acting beta2-agonists
Trial: 14600189
Drug: Domiciliary oxygen
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Domiciliary oxygen therapy
Trial: 8977745
Drug: 20 mg/day
RxNorm normalized name: futibatinib 20 mg/day (4 mg x 5) ORAL TABLET
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 20 mg/day carbimazole
Trial: 27654971
Drug: AZD8931 20
FDA approved: no
EMA approved: no
PMDA approved: no
Description: AZD8931 20 mg
Trial: 27654971
Drug: AZD8931 40
FDA approved: no
EMA approved: no
PMDA approved: no
Description: AZD8931 40 mg
Trial: 20831889
Drug: Oral-appliance therapy
RxNorm normalized name: Monistat Simple Therapy
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Oral-appliance therapy
Trial: 16911345
Drug: Oxcarbazepine (1200
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Oxcarbazepine (1200 mg/day)
Trial: 16002074
Drug: Fluvastatin 40
RxNorm normalized name: fluvastatin 40 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Fluvastatin 40 mg
Trial: 9129477
Drug: Calcium supplement
RxNorm normalized name: Calcium supplement
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Calcium supplement (1000 mg supplemental Ca/d as calcium citrate malate)
Trial: 30715100
Drug: Blood pressure
RxNorm normalized name: Blood Pressure Kit
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Blood pressure treatment goal
Trial: 28969626
Drug: AyuFlex2 (500
FDA approved: no
EMA approved: no
PMDA approved: no
Description: AyuFlex2 (500 mg twice daily)
Trial: 28969626
Drug: AyuFlex1 (250
FDA approved: no
EMA approved: no
PMDA approved: no
Description: AyuFlex1 (250 mg twice daily)
Trial: 25277305
Drug: 2.0 mg
RxNorm normalized name: LORAZEPAM 2.0 mg in 1 mL INTRAVENOUS INJECTION
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 2.0 mg intravitreal ranibizumab injections
Trial: 25277305
Drug: 0.5 mg
RxNorm normalized name: biotin 0.5 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 0.5 mg intravitreal ranibizumab injections
Trial: 16112244
Drug: Lisinopril (20
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Lisinopril (20 mg once daily for 24 weeks)
Trial: 16112244
Drug: Telmisartan (80
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Telmisartan (80 mg once daily for 24 weeks)
Trial: 9129478
Drug: Moderate protein
RxNorm normalized name: protein C
DrugBank: Protein C (DB11312)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Moderate protein (MP; 23 g)
Trial: 9129478
Drug: Moderate protein
RxNorm normalized name: protein C
DrugBank: Protein C (DB11312)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Moderate protein plus potassium bicarbonate (MP+K; 23 g + 23 mmol KHCO3)
Trial: 24940942
Drug: 4 L
RxNorm normalized name: PEG-4 laurate
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 4 L PEG in the morning on the day of colonoscopy
Trial: 24940942
Drug: 2 L
RxNorm normalized name: H-2 locus
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 2 L split doses of PEG
Trial: 20215961
Drug: Tramadol ER
RxNorm normalized name: tramadol Extended Release Oral Capsule
DrugBank: Tramadol (DB00193)
FDA approved: yes
EMA approved: no
PMDA approved: yes
Description: Tramadol ER 100 mg
Trial: 20215961
Drug: Tramadol ER
RxNorm normalized name: tramadol Extended Release Oral Capsule
DrugBank: Tramadol (DB00193)
FDA approved: yes
EMA approved: no
PMDA approved: yes
Description: Tramadol ER 200 mg
Trial: 20215961
Drug: Tramadol ER
RxNorm normalized name: tramadol Extended Release Oral Capsule
DrugBank: Tramadol (DB00193)
FDA approved: yes
EMA approved: no
PMDA approved: yes
Description: Tramadol ER 300 mg
Trial: 18358082
Drug: Tramadol ER
RxNorm normalized name: tramadol Extended Release Oral Capsule
DrugBank: Tramadol (DB00193)
FDA approved: yes
EMA approved: no
PMDA approved: yes
Description: Tramadol ER 400 mg
Trial: 10418911
Drug: Reduced antigen
RxNorm normalized name: TRICOPHYTON ANTIGEN
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Reduced antigen formulation (dtpa, SmithKline Beecham Biologicals)
Trial: 10418911
Drug: Experimental low
RxNorm normalized name: low-density polyethylene
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Experimental low dose formulation (dtpa-exp; d and t, Michigan Biologic Products Institute)
Trial: 2405089
Drug: Controlled-release metoprolol
RxNorm normalized name: metoprolol Extended Release Oral Capsule
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Controlled-release metoprolol 200 mg once daily
Trial: 9535211
Drug: High-dose chemotherapy
FDA approved: no
EMA approved: no
PMDA approved: no
Description: High-dose chemotherapy with peripheral blood progenitor cell transplantation (PBPCT) after two cycles of conventional chemotherapy (etoposide 500 mg/m2, ifosfamide 4 g/m2, cisplatin 50 mg/m2, epirubicin 50 mg/m2 plus granulocyte colony-stimulating factor 5 microg/kg) followed by high-dose etoposide 1,500 mg/m2, ifosfamide 12 g/m2, carboplatin 750 mg/m2, and epirubicin 150 mg/m2 with PBPCT.
Trial: 9535211
Drug: Surgical resection
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Surgical resection in stages I to IIIA patients before high-dose chemotherapy.
Trial: 7614524
Drug: Extended-release 5-ISMN
RxNorm normalized name: ISMN
DrugBank: Isosorbide mononitrate (DB01020)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Extended-release 5-ISMN 120 mg once daily
Trial: 7614524
Drug: ISDN 40
RxNorm normalized name: ISDN 40 MG Oral Tablet
FDA approved: no
EMA approved: no
PMDA approved: no
Description: ISDN 40 mg every 6 hours
Trial: 406602
Drug: Verapamil, 80
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Verapamil, 80 mg three times/day
Trial: 406602
Drug: Practolol, 100
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Practolol, 100 mg three times/day
Trial: 24033910
Drug: Intraventricular injection
RxNorm normalized name: Brineura 150 MG in 5 mL Intraventricular Injection
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Intraventricular injection of low-dose rtPA
Trial: 24033910
Drug: Placebo (intraventricular
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Placebo (intraventricular injection of normal saline)
Trial: 1803995
Drug: Zidovudine 1500
RxNorm normalized name: Zidovudine
DrugBank: Zidovudine (DB00495)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Zidovudine 1500 mg daily
Trial: 1803995
Drug: Zidovudine 600
RxNorm normalized name: Zidovudine
DrugBank: Zidovudine (DB00495)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Zidovudine 600 mg daily plus acyclovir 4800 mg daily
Trial: 1803995
Drug: Zidovudine 1500
RxNorm normalized name: Zidovudine
DrugBank: Zidovudine (DB00495)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Zidovudine 1500 mg daily plus acyclovir 4800 mg daily
Trial: 1803995
Drug: High doses
RxNorm normalized name: high-density polyethylene
FDA approved: no
EMA approved: no
PMDA approved: no
Description: High doses of zidovudine
Trial: 1803995
Drug: Zidovudine with
RxNorm normalized name: Zidovudine
DrugBank: Zidovudine (DB00495)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Zidovudine with high-dose acyclovir
Trial: 6519349
Drug: Aspirin/Caffeine combination
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Aspirin/Caffeine combination (800 mg aspirin, 65 mg caffeine)
Trial: 19460503
Drug: Everolimus and
RxNorm normalized name: Everolimus
DrugBank: Everolimus (DB01590)
FDA approved: yes
EMA approved: yes
PMDA approved: yes
Description: Everolimus and low-dose Cyclosporine (EVL)
Trial: 770329
Drug: Attenuated rubella
RxNorm normalized name: Live attenuated rubella vaccine
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Attenuated rubella virus vaccine (administered by nose drops or subcutaneous route)
Trial: 770329
Drug: Nose drops
RxNorm normalized name: Nose Drops
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Nose drops and subcutaneous route groups
Trial: 28768651
Drug: RCE (60
FDA approved: no
EMA approved: no
PMDA approved: no
Description: RCE (60 mg isoflavone aglycones/d and probiotics)
Trial: 21914263
Drug: Control group
RxNorm normalized name: meningococcal group B vaccine Prefilled Syringe [Trumenba]
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Control group (no surgical treatment)
Trial: 17597267
Drug: Plasmids encoding
RxNorm normalized name: plasmin
DrugBank: Fibrinolysin (DB05254)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Plasmids encoding type 1 and type 2 E2 administered to mice
Trial: 1968000
Drug: Levonorgestrel and
RxNorm normalized name: levonorgestrel and estrogen
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Levonorgestrel and ethinyl oestradiol (0.15 mg levonorgestrel and 0.03 mg ethinyl oestradiol)
Trial: 1968000
Drug: Desogestrel and
RxNorm normalized name: desogestrel and estrogen
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Desogestrel and ethinyl oestradiol (0.15 mg desogestrel and 0.03 mg ethinyl oestradiol)
Trial: 31577451
Drug: Pioglitazone (a
RxNorm normalized name: pioglitazone (as hydrochloride)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Pioglitazone (a PPARÎ³ agonist)
Trial: 31577451
Drug: PPARÎ³ agonists
FDA approved: no
EMA approved: no
PMDA approved: no
Description: PPARÎ³ agonists of the TZD-class
Trial: 28855352
Drug: Low-dose cyclophosphamide
RxNorm normalized name: ethinyl estradiol
DrugBank: Ethinylestradiol (DB00977)
FDA approved: yes
EMA approved: no
PMDA approved: yes
Description: Low-dose cyclophosphamide (50 mg twice a day for 2 weeks)
Trial: 26683252
Drug: Standard smoking
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Standard smoking cessation treatment plus exercise and counseling (n = 35)
Trial: 24180163
Drug: Ketamine (0.25
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Ketamine (0.25 mg/kg)
Trial: 8698872
Drug: Intraarticular morphine
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Intraarticular morphine
Trial: 8610863
Drug: Combination of
RxNorm normalized name: combination of rauwolfia alkaloids and diuretics incl. other combinations
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Combination of intraarticular ketorolac and morphine
Trial: 8408733
Drug: Nifedipine (20
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Nifedipine (20 mg orally)
Trial: 4067783
Drug: Lactose (Group
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Lactose (Group L)
Trial: 26873052
Drug: Supplemental measles
RxNorm normalized name: MEASLES VIRUS
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Supplemental measles vaccine (sMV) administered at median age of 20 months after 1 or 2 doses of primary measles vaccination
Trial: 26873052
Drug: Supplemental measles
RxNorm normalized name: MEASLES VIRUS
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Supplemental measles vaccine (sMV) administered at median age of 20 months after 2 doses of primary measles vaccination
Trial: 15825029
Drug: gD vaccine
RxNorm normalized name: Pertussis vaccine
DrugBank: Pertussis vaccine (DB15274)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: gD vaccine with adjuvants (alum and MPL)
Trial: 2880218
Drug: Cyclosporin therapy
RxNorm normalized name: Cyclosporine
DrugBank: Cyclosporine (DB00091)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Cyclosporin therapy
Trial: 2696550
Drug: Felbinac gel
RxNorm normalized name: felbinac
DrugBank: Felbinac (DB07477)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Felbinac gel applied three times daily
Trial: 1011296
Drug: Aspartame (1.8
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Aspartame (1.8 g administered three times daily with meals)
Trial: 25958714
Drug: TIVA (propofol
FDA approved: no
EMA approved: no
PMDA approved: no
Description: TIVA (propofol to reach 8 mcg/ml)
Trial: 15184611
Drug: Natalizumab 1
RxNorm normalized name: Natalizumab 150 mg/mL solution for injection
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Natalizumab 1 mg/kg
Trial: 15184611
Drug: Natalizumab (both
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Natalizumab (both doses)
Trial: 10069551
Drug: Ritanserin 2.5
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Ritanserin 2.5 mg/day
Trial: 10069551
Drug: Ritanserin 5
RxNorm normalized name: ketanserin
DrugBank: Ketanserin (DB12465)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Ritanserin 5 mg/day
Trial: 10069551
Drug: Ritanserin 10
RxNorm normalized name: ketanserin
DrugBank: Ketanserin (DB12465)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Ritanserin 10 mg/day
Trial: 31148099
Drug: Nimodipine 90
RxNorm normalized name: Nimodipine
DrugBank: Nimodipine (DB00393)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Nimodipine 90 mg/die t.i.d plus placebo b.i.d
Trial: 29142011
Drug: Mediterranean/low-carbohydrate (MED/LC)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Mediterranean/low-carbohydrate (MED/LC) diet + 28 g walnuts/day
Trial: 7128192
Drug: 100 mg
RxNorm normalized name: urea 100 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 100 mg indomethacin at night
Trial: 27055824
Drug: Ashwagandha (300
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Ashwagandha (300 mg) twice daily
Trial: 15271690
Drug: Testosterone injections
RxNorm normalized name: Testosterone
DrugBank: (1,2,6,7-3H)Testosterone (DB14093)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Testosterone injections (100 mg of testosterone enanthate injected weekly)
Trial: 15271690
Drug: Testosterone injections
RxNorm normalized name: Testosterone
DrugBank: (1,2,6,7-3H)Testosterone (DB14093)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Testosterone injections + Resistance training
Trial: 11966550
Drug: Epidural ropivacaine
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Epidural ropivacaine (2 mg.ml(‐1))
Trial: 11966550
Drug: Ropivacaine (2
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Ropivacaine (2 mg.ml(‐1)) with sufentanil (1 microg.ml(‐1))
Trial: 2092965
Drug: Urapidil (30mg,
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Urapidil (30mg, 60mg, or 90mg twice daily)
Trial: 30239610
Drug: Baseline plasma
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Baseline plasma 25(OH)D >33.6 ng/mL
Trial: 30239610
Drug: Baseline plasma
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Baseline plasma 25(OH)D <20 ng/mL
Trial: 10420027
Drug: KTP/Nd:YAG laser
FDA approved: no
EMA approved: no
PMDA approved: no
Description: KTP/Nd:YAG laser treatment
Trial: 31345359
Drug: 30 mg/d
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 30 mg/d zinc (as zinc gluconate) for 12 weeks
Trial: 19739499
Drug: Biobloc appliance
RxNorm normalized name: ethanol
DrugBank: Ethanol (DB00898)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Biobloc appliance treatment
Trial: 17966440
Drug: ACEI plus
FDA approved: no
EMA approved: no
PMDA approved: no
Description: ACEI plus antiarrhythmic (Propafenona, 450 mg daily)
Trial: 17966440
Drug: Antiarrhythmic (Propafenona,
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Antiarrhythmic (Propafenona, 450 mg daily)
Trial: 3302542
Drug: Cefuroxime administered
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Cefuroxime administered intraincisionally before surgery and immediately after surgery (total 5,250 mg)
Trial: 3302542
Drug: Cefuroxime administered
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Cefuroxime administered only postoperatively (total 5,250 mg)
Trial: 29262978
Drug: Varenicline combined
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Varenicline combined with nicotine replacement therapy (NRT)
Trial: 22272505
Drug: Sequential presentation
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Sequential presentation mode condition (visual working memory)
Trial: 10694308
Drug: Terbinafine 1%
RxNorm normalized name: Terbinafine 1% Topical application Gel/Jelly
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Terbinafine 1% emulsion-gel
Trial: 3902954
Drug: Oral cholecystography
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Oral cholecystography (OCG)
Trial: 1393414
Drug: Combination of
RxNorm normalized name: combination of rauwolfia alkaloids and diuretics incl. other combinations
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Combination of US and OCG
Trial: 3531310
Drug: Ranitidine 150
RxNorm normalized name: ranitidine 150 MG
DrugBank: Ranitidine (DB00863)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Ranitidine 150 mg b.i.d. for 6 weeks
Trial: 21383275
Drug: School-based care
FDA approved: no
EMA approved: no
PMDA approved: no
Description: School-based care group (preventive medications administered by school nurses)
Trial: 19698035
Drug: Spinal-epidural anesthesia
RxNorm normalized name: Bos taurus spinal cord preparation
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Spinal-epidural anesthesia plus intravenous patient-controlled anesthesia with tramadol
Trial: 19698035
Drug: General anesthesia
RxNorm normalized name: Ethers for general anesthesia
FDA approved: no
EMA approved: no
PMDA approved: no
Description: General anesthesia (propofol induction, maintenance with sevoflurane) plus intravenous patient-controlled anesthesia with tramadol
Trial: 17904943
Drug: Soy milk
RxNorm normalized name: DIMETHICONE 4 g in 100 g CUTANEOUS PATCH [FERMENTED SOY MILK WRINKLE CARE SLEEPING MASK]
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Soy milk (720 mL daily)
Trial: 7948760
Drug: Direct Fluorescent
RxNorm normalized name: direct blue 2
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Direct Fluorescent Antibody (DFA) testing
Trial: 29973252
Drug: Smartphone-delivered cognitive
RxNorm normalized name: DELIVER
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Smartphone-delivered cognitive behavioral therapy (CBT) components including self-monitoring, cognitive restructuring, behavioral activation, assertion training, and problem solving.